Quarterly report pursuant to Section 13 or 15(d)

Stock Options, Restricted Stock Units and Warrants

v3.22.2.2
Stock Options, Restricted Stock Units and Warrants
9 Months Ended
Sep. 30, 2022
Stock Options, Restricted Stock Units And Warrants [Abstract]  
Stock Options, Restricted Stock Units and Warrants

Note 8 - Stock Options, Restricted Stock Units and Warrants:

 

On December 16, 2020, the Company adopted its 2020 Long-Term Incentive Plan (the “2020 Plan”). Under the 2020 Plan, there are 5,333,333 shares of the Company’s common stock available for issuance and the 2020 Plan has a term of 10 years. The available shares in the 2020 Plan will automatically increase on the first trading day in January of each calendar year during the term of this Plan, commencing with January 2021, by an amount equal to the lesser of (i) five percent (5%) of the total number of shares of common stock issued and outstanding on December 31 of the immediately preceding calendar year, (ii) 1,000,000 shares of common stock or (iii) such number of shares of common stock as may be established by the Company’s Board of Directors.

 

The Company grants equity-based compensation under its 2020 Plan and its 2016 Equity Incentive Plan (the “2016 Plan”). The 2020 Plan and 2016 Plan allows the Company to grant incentive and nonqualified stock options, and shares of restricted stock to its employees, directors and consultants. On June 14, 2019, the Board of Directors of the Company approved increasing the number of shares allocated to the Company’s 2016 Equity Incentive Plan from 5,500,000 to 7,333,333.

 

Under the 2016 Plan and the 2020 Plan, upon the exercise of stock options and issuance of fully vested restricted common stock, shares of common stock may be withheld to satisfy tax withholdings.

 

Stock-based compensation:

 

The Company recognized total expenses for stock-based compensation during the three and nine months ended September 30, 2022 and 2021, which are included in the accompanying statements of operations, as follows (in thousands):

 

    Three months ended
September 30,
    Nine months ended
September 30,
 
    2022     2021     2022     2021  
                         
Research and development expenses   $ 136     $ 113     $ 636     $ 647  
Selling, general and administrative expenses     344       2,988       2,375       8,503  
Total stock-based compensation   $ 480     $ 3,101     $ 3,011     $ 9,150  

 

Stock Options:

 

The Company provides stock-based compensation to employees, directors and consultants under both the 2016 and 2020 Plans. The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option pricing model. The Company historically has been a private company and lacks company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a publicly traded set of peer companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The risk-free interest rate is determined by referencing the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future.

 

The Company utilized assumptions in the estimation of fair value of stock-based compensation for the three and nine months ended September 30, 2022 and 2021 as follows:

 

    Three months ended
September 30,
  Nine months ended
September 30,
    2022   2021   2022   2021
Dividend yield   0%   0%   0%   0%
Expected price volatility   88.8%   50.0%   88.8% - 91.7%   50.0%
Risk free interest rate   3.96%   0.66% - 1.12%   3.96% - 3.25%   0.22% - 1.12%
Expected term   5.0 - 6.5 years   6.0 - 7.0 years   5.0 - 7.0 years   3.0 - 7.0 years

 

A summary of activity under the 2016 and 2020 Plans for the nine months ended September 30, 2022 is as follows:

 

    Shares Underlying
Options
    Weighted Average
Exercise
Price
    Weighted Average
Remaining Contractual
 Term
(Years)
    Aggregate Intrinsic
Value
 
Outstanding at December 31, 2021     11,135,432     $ 2.85       7.6     $ 13,031  
Granted     832,500     $ 0.40       -          
Canceled     (652,776 )   $ 3.50      
-
         
Forfeited     (1,476,670 )   $ 2.60      
-
         
Outstanding at September 30, 2022     9,838,486     $ 2.63       6.9     $ 53  
                                 
Exercisable at September 30, 2022     8,513,589     $ 2.79       6.5     $ 53  

 

During the nine months ended September 30, 2022, the Company cancelled 652,776 stock options with a weighted average exercise price of $3.50 per share. Of these stock option cancellations, 33,332 were related to an exchange for restricted stock units (see restricted stock units below) and 619,444 stock options were canceled in connection with employee departures.

 

During the nine months ended September 30, 2022 the Company modified the expiration dates of 789,527 vested stock options related to terminated employees. The modification of the equity awards modified the expiration date based on the options original terms. During the nine months ended September 30, 2022, the Company recognized incremental stock-based compensation of $0.6 million.

 

Restricted stock units:

 

A summary of the Company’s restricted stock activity during the nine months ended September 30, 2022 is as follows:

 

    Number of
Shares
    Weighted
Average
Grant-Date
 Fair Value
 
Unvested at December 31, 2021     1,939,683     $ 3.40  
Granted     576,350     $ 0.62  
Vested     (566,666 )   $ 2.81  
Issued     (1,061,905 )   $ 4.50  
Unvested at September 30, 2022     887,462     $ 2.30  

 

During the nine months ended September 30, 2022, the Company granted 576,350 restricted stock units (“RSUs”) to employees and members of its board of directors with a fair value of approximately $0.35 million. Included in the RSUs granted during 2022, 33,332 RSUs were exchanged for 33,332 cancelled stock options. The cancellation of the stock options and the issuance of the RSUs was accounted for as a modification of the equity awards, and during the nine months ended September 30, 2022, the Company recognized incremental stock-based compensation of $0.1 million.

 

During the nine months ended September 30, 2022, the Company accelerated the vesting of 242,593 RSU’s. The accelerated vesting was accounted for as a modification of the equity awards, and during the nine months ended September 30, 2022 the Company recognized incremental stock-based compensation of $0.3 million.

 

Warrants:

 

Hudson Pacific Properties, L.P.

 

On August 12, 2022, the Company entered into two Purchase Orders (PO’s) with Hudson Pacific Properties, L.P. (“Hudson”) for the purchase of the Company’s Smart Window Inserts™ (“Inserts”). Hudson is a unique provider of end-to-end real estate solutions for tech and media tenants. The PO’s have a value of $85,450 and represent the first orders the Company has received prior to the launch of its Inserts. Delivery and installation are expected to begin in December 2022.

 

On August 12, 2022, as additional consideration for the PO’s, the Company issued a warrant to Hudson to purchase 300,000 shares of the Company’s common stock at $0.75 per share. The warrant has a five-year life and expires on August 12, 2027.

 

Because Hudson is a customer, the Company accounts for the PO’s and warrants under Accounting Standards Codification (“ASC”) 606 Revenue Recognition (“ASC 606”). As the performance obligations have not yet been satisfied, the Company has not recognized any revenue during the nine months ended September 30, 2022.

 

The Company accounts for the equity-classified warrant as consideration payable to a customer under ASC 606, as it relates to the future purchase of the Inserts. Pursuant to ASC 718 Compensation - Stock Compensation (“ASC 718”), the Company measured the fair value of the warrant using the Black-Scholes valuation model on the issuance date, with the value being recognized as a prepaid asset up to the recoverable value represented by the value of the contract. The fair value of the warrant on the issuance date totaled $161,700, and as of September 30, 2022, the Company recorded a prepaid asset of $85,450, representing the recoverable value from the PO’s, which is included in prepaid and other current assets on the accompanying condensed balance sheet.

 

SLOC

 

In connection with the SLOC, the Company issued a warrant for 200,000 shares of common stock with an exercise price of $2.00, and a total fair value of approximately $0.2 million. This amount is included in the condensed balance sheet as deferred debt issuance costs included in other assets.

 

A summary of the Company’s warrant (excluding penny warrants) activity during the nine months ended September 30, 2022 is as follows:

 

    Shares
Underlying
Warrants
    Weighted
Average
Exercise Price
    Weighted
Average
Remaining
Contractual
Term
(Years)
    Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2021     4,525,177     $ 2.65       4.0     $ 7,088  
Issued     1,376,602     $ 1.26                  
Outstanding at September 30, 2022     5,901,779     $ 2.32       3.6     $ -  

 

No warrants were exercisable at of September 30, 2022.

 

The Company estimated the fair value of the warrants using the Black-Scholes pricing model as follows:

 

    Three months ended
September 30,
  Nine months ended
September 30,
    2022   2021   2022   2021
Expected price volatility   87.3%-87.5%   50.0%   87.3%-103.0%   50.0%
Risk free interest rate   2.9%-3.0%   0.8%-1.0%   2.2%-3.0%   0.4%-1.0%
Expected term (years)   5.0   5.0   5.0   5.0